feed,title,long_url,short_url
Benzinga,"Microcap Firm ZyVersa Therapeutics Shows Promise Despite IPO Volatility, Analyst Initiates With Buy",https://benzinga.com/analyst-ratings/analyst-color/23/09/34367408/microcap-firm-zyversa-therapeutics-shows-promise-despite-ipo-volatility-analyst-ini,https://da.gd/UDM6
Benzinga,Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst,https://benzinga.com/general/biotech/23/09/34366749/breast-cancer-focused-atossa-therapeutics-can-possibly-change-treatment-paradigm-analyst,https://da.gd/rx937o
